Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials

BACKGROUND: Monoclonal antibodies of anti-epidermal growth factor receptor (EGFR) have been recommended as first-line therapy for patients with left-sided metastatic colorectal cancer (mCRC) with wild-type RAS. The effect of tumour laterality on antivascular endothelial growth factor antibody and ho...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Xia-Hong, Jiang, Yu-Huan, Fang, Zhou, Sun, Fan, Li, Yao, Wang, Wei, Xia, Zi-Jin, Wang, Xiao-Zhong, Ying, Hou-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064070/
https://www.ncbi.nlm.nih.gov/pubmed/32132090
http://dx.doi.org/10.1136/esmoopen-2019-000605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064070/
https://www.ncbi.nlm.nih.gov/pubmed/32132090
http://dx.doi.org/10.1136/esmoopen-2019-000605

Ejemplares similares